Teleflex (NYSE:TFX) Shares Gap Up After Analyst Upgrade

Teleflex Incorporated (NYSE:TFX)’s share price gapped up prior to trading on Friday after Raymond James Financial upgraded the stock from a market perform rating to an outperform rating. The stock had previously closed at $110.49, but opened at $114.54. Raymond James Financial now has a $128.00 price target on the stock. Teleflex shares last traded at $114.9940, with a volume of 229,944 shares changing hands.

TFX has been the topic of a number of other research reports. Wall Street Zen cut Teleflex from a “hold” rating to a “sell” rating in a research note on Saturday, March 7th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research report on Monday, December 29th. Wells Fargo & Company boosted their price target on Teleflex from $116.00 to $130.00 and gave the stock an “equal weight” rating in a research note on Friday, February 27th. Needham & Company LLC raised their price objective on Teleflex from $138.00 to $147.00 and gave the company a “buy” rating in a research note on Thursday, February 26th. Finally, Zacks Research downgraded Teleflex from a “hold” rating to a “strong sell” rating in a report on Monday, March 2nd. Three equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $139.00.

Trending Headlines about Teleflex

Here are the key news stories impacting Teleflex this week:

• Positive Sentiment: Irenic, a ~2% Teleflex shareholder, called for the Board to form a strategic-review sub‑committee with independent directors and to engage potential acquirers — a direct catalyst for takeover interest that can lift valuation expectations. Irenic Comments on Teleflex’s Announcement That It Is Open to Strategic Alternatives
• Positive Sentiment: Raymond James upgraded Teleflex from Market Perform to Outperform with a $128 price target, signaling analyst conviction that there’s upside from either operational improvement or strategic outcomes. Raymond James upgrade coverage
• Neutral Sentiment: Teleflex issued a formal statement reiterating its commitment to value‑maximizing strategies and said management met with Irenic on March 19 to understand their views — indicates engagement but not yet a formal review process. Teleflex Reiterates Commitment to Value‑Maximizing Strategies and Strong Execution
• Neutral Sentiment: Other shareholders and outlets are echoing calls for Teleflex to engage potential buyers, adding public pressure that could push the Board toward a more formal process. Teleflex shareholder urges company engage buyers
• Negative Sentiment: Teleflex pushed back, saying Irenic falsely claimed the company was not open to buyout offers — the public dispute raises governance/uncertainty risk and could deter some bidders or prolong a process. Teleflex says Irenic falsely claimed company was not open for buyout offers
• Negative Sentiment: Fundamentals remain a headwind: Teleflex reported a large recent earnings and revenue miss and guidance that reflects recovery needs — operational weakness could limit strategic options or depress standalone valuation until results improve.

Institutional Investors Weigh In On Teleflex

Institutional investors have recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB raised its holdings in Teleflex by 57.9% during the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock worth $26,000 after buying an additional 77 shares during the period. Banque Cantonale Vaudoise raised its holdings in shares of Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after acquiring an additional 113 shares during the period. Hantz Financial Services Inc. lifted its position in shares of Teleflex by 40.5% in the 4th quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company’s stock valued at $48,000 after acquiring an additional 113 shares in the last quarter. UMB Bank n.a. lifted its stake in Teleflex by 57.1% in the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after acquiring an additional 113 shares in the last quarter. Finally, Maryland State Retirement & Pension System lifted its position in shares of Teleflex by 1.5% in the fourth quarter. Maryland State Retirement & Pension System now owns 8,652 shares of the medical technology company’s stock worth $1,056,000 after purchasing an additional 129 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Stock Performance

The firm’s fifty day moving average is $109.07 and its 200 day moving average is $116.76. The firm has a market capitalization of $5.14 billion, a price-to-earnings ratio of -5.66, a PEG ratio of 0.69 and a beta of 0.87. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.54 and a quick ratio of 2.01.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, February 26th. The medical technology company reported $1.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.73 by ($1.80). Teleflex had a positive return on equity of 14.30% and a negative net margin of 30.56%.The firm had revenue of $569.00 million for the quarter, compared to analysts’ expectations of $912.57 million. During the same quarter in the prior year, the business posted $3.89 earnings per share. Teleflex’s revenue was down 28.5% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Friday, March 6th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Friday, March 6th. Teleflex’s dividend payout ratio is -6.62%.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.